section name header

Indications

High Alert


Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: hypotension, bradycardia

Derm: flushing, pruritus, sweating

EENT: diplopia, blurred vision, miosis

GI: constipation, vomiting, dry mouth, nausea

GU: urinary retention

Neuro: confusion, sedation, dizziness, dysphoria, euphoria, floating feeling, hallucinations, headache, unusual dreams

Resp: RESPIRATORY DEPRESSION (INCLUDING CENTRAL SLEEP APNEA AND SLEEP-RELATED HYPOXEMIA)

Misc: allodynia, opioid-induced hyperalgesia, psychological dependence, physical dependence, tolerance

Interactions

Drug-drug:

Drug-Natural Products:

Availability

(Generic available)

Route/Dosage

Action

  • Binds to opiate receptors in the CNS, altering perception of and response to pain.
  • Produces generalized CNS depression.
Therapeutic effects:
  • Decreased pain.

Classifications

Therapeutic Classification: opioid analgesics

Pharmacologic Classification: opioid agonists

Pharmacokinetics

Absorption: Well absorbed following oral administration.

Distribution: Extensive.

Metabolism/Excretion: Mostly metabolized by the liver.

Half-Life: 12–16 hr; may be as long as 30 hr with chronic dosing.

Contr. Subst. Schedule

Schedule II (C-II)

Time/Action Profile

(analgesic effect)

ROUTEONSETPEAKDURATION
PO10–60 min90–120 min4–5 hr



Patient/Family Teaching

Pronunciation

lee-VOR-fan-ole